Filter
480
Filtered Results: 480
Text search:
genotypic
testing
Featured
Recommendations
62
New Publications
141
Language
Document type
No document type
293
Guidelines
80
Studies & Reports
59
Manuals
25
Strategic & Response Plan
12
Fact sheets
6
Brochures
2
Training Material
1
Situation Updates
1
Infographics
1
Countries / Regions
India
21
Western and Central Europe
19
Eastern Europe
11
Africa
10
South Africa
10
Rwanda
9
Nigeria
9
Latin America and the Carribbean
9
Ethiopia
8
Nepal
7
Russia
7
Global
6
Namibia
6
Zambia
6
Kenya
5
Malawi
5
Philippines
5
Mozambique
5
Sierra Leone
4
Peru
4
Zimbabwe
4
Asia
4
Tanzania
4
Germany
4
South–East Asia Region
4
Myanmar / Burma
4
Ukraine
3
Cameroon
3
Cambodia
3
Bangladesh
3
Uganda
3
Indonesia
3
North Macedonia
2
Colombia
2
Lesotho
2
Ghana
2
Senegal
2
Estonia
2
USA
2
Venezuela
2
Congo, Democratic Republic of
2
Western Pacific Region
2
Argentina
2
Brazil
2
Georgia
2
Botswana
2
Liberia
2
Timor Leste/ East Timor
1
Thailand
1
Benin
1
Togo
1
Chile
1
Iran
1
Albania
1
Jordan
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
North America
1
Portugal
1
Bolivia
1
Central African Republic
1
Mali
1
Angola
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
143
Clinical Guidelines
91
Public Health
21
Pharmacy & Technologies
19
Key Resources
8
Women & Child Health
5
Capacity Building
3
Toolboxes
TB
108
HIV
71
AMR
27
NTDs
20
COVID-19
17
Pharmacy
15
Rapid Response
14
Refugee
14
Mental Health
10
Planetary Health
7
Zika
6
Ebola
5
NCDs
5
Polio
5
Caregiver
3
Natural Hazards
2
Conflict
2
Specific Hazards
1
Disability
1
Cholera
1
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month period
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care...
This study aimed to understand the patterns of HIV drug resistance in pregnant women in Mozambique. This might help in tailoring optimal regimens for prevention of mother to child transmission of HIV (pMTCT) and antenatal care.
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
Prepared as an outcome of ICMR Expert Group on Immunophenotyping of Hematolymphoid Neoplasms | Coordinated by Division of Non Communicable Diseases | This document addresses on various issue related to good quality practices in laboratory work up of flow cytometric immunophenotyping and will be of u...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
6th edition
Meeting Report
27–30 June 2017 Manila, Philippines
Unofficial Translation
Approved by the Federal Government on October 20, 2016
Le défi des pays en voie de développement est la disponibilité de méthodes de diagnostic rapide et précis pour le management de la tuberculose. Des techniques moléculaires offrent cet avantage et nous avons utilisé le test GeneXpert MTB/RIF dans le diagnostic de la tuberculose extra-pulmonair...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
WHO-2019-nCoV-genomic_sequencing
